Carregant...
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Loss-of-function mutations in BRCA1 and BRCA2 are detected in at least 5% of unselected patients with breast cancer (BC). These BC susceptibility genes encode proteins critical for DNA homologous recombination repair (HRR). This review provides an update on oral poly(ADP-ribose) polymerase (PARP) in...
Guardat en:
| Publicat a: | Target Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8105250/ https://ncbi.nlm.nih.gov/pubmed/33710534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-021-00796-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|